PTPRG and Miyoshi myopathy: Our findings highlighted PTPRG as a gene whose high expression is linked to this aggressive phenotype and poor clinical outcomes in MM, yet intriguingly, its knockdown in vitro impairs MM cell survival, suggesting a complex, context-dependent pro-survival function in these cells that warrants deeper exploration as a potential therapeutic vulnerability.